Clinical trial

Valued EpiGenetic Glycemic ImprovEments Through Weight Loss

NCT02869659

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2016-11-01

PhaseNA

Study timeline

Study start (actual)2016-11-01Date precision: day

Registry last updated2020-12-31

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Obesityunresolved

Pre-diabetesunresolved

Interventions

Weight Loss GroupBEHAVIORAL

Delayed Weight LossBEHAVIORAL

Sponsors & collaborators

Wake Forest University Health Scienceslead sponsor

Medifast, Inc.collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)collaborator

Mapped research locations

Winston-SalemNorth Carolina, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02869659 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.